This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Genentech, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Matthew Leo Landry
Introduction
Matthew Leo Landry is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of cancer treatment through his innovative work. His expertise and dedication have led to the development of a unique patent that showcases his commitment to advancing medical science.
Latest Patents
Matthew holds a patent for "Aza-tetracyclic oxazepine compounds and uses thereof." This patent presents aza-tetracyclic oxazepinyl compounds that are useful in the treatment of cancers. His work in this area highlights the potential for new therapeutic options for patients battling this challenging disease.
Career Highlights
Matthew is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech allows him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to medical research and development.
Collaborations
Some of Matthew's notable coworkers include Christian Nilewski and Michael Siu. Their collaboration fosters a dynamic environment that encourages the exchange of ideas and the pursuit of groundbreaking solutions in the field of cancer treatment.
Conclusion
Matthew Leo Landry's work exemplifies the spirit of innovation in the medical field. His patent and contributions at Genentech, Inc. reflect his dedication to improving cancer treatment options. Through his efforts, he continues to make a meaningful impact on the lives of patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile